European Innovation Council

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

David Malo Jean

Director

Candace Johnson

President

Past deals in Software

Deeploy

Grant in 2025
Deeploy is a developer of a machine learning operations platform focused on enhancing the accountability and transparency of AI systems. The platform centralizes explainable AI (XAI) within machine learning operations (MLOps), empowering users to comprehend how models function and to rectify automated decisions when necessary. By organizing deployments, tracking model performance, generating trace logs, and facilitating the creation of custom models and explainers, Deeploy provides data scientists and users with the tools needed to understand the implications and applications of machine learning models. This approach ensures that AI systems are both trustworthy and accountable.

Hideez

Grant in 2024
Hideez is a cybersecurity startup that specializes in providing solutions for both physical and logical access. With offices in the USA and Ukraine, the company has developed the Hideez Key, a hybrid device designed for wireless authentication and password management. This innovative solution integrates RFID door credentials and digital signatures, utilizing encrypted Bluetooth, RFID, and NFC technologies. Hideez Key offers a versatile approach to authentication, enabling users to manage and replace credentials remotely. Its proprietary encryption protocols are platform agnostic and are designed to enhance existing solutions in the market. Overall, Hideez aims to simplify identity and access management while ensuring the security of digital assets.

Multiverse Computing

Series A in 2024
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.

VSORA

Grant in 2023
VSORA is an intellectual property provider based in France, specializing in digital signal processing (DSP) technology for chipmakers focused on next-generation digital communications systems, particularly 5G networks. Established in 2015 by a team of experienced DSP engineers, the company offers a powerful multi-core DSP architecture that eliminates the necessity for DSP co-processors, thereby enhancing design flexibility. VSORA's innovative DSP development flow enables collaboration between signal processing engineers and software engineers, allowing them to work within the same environment and share source code, which significantly accelerates the time-to-market for new products. The company's mission is to address technical challenges by optimizing DSP computing power while minimizing power consumption and silicon footprint, thereby improving overall system performance.

PASQAL

Grant in 2023
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

EyeControl

Venture Round in 2023
EyeControl is a pioneer in medical technology focused on innovative communication solutions for healthcare. The company has developed a unique device aimed at improving the quality of life for patients with locked-in syndrome, particularly those suffering from ALS. This device consists of a simple glass frame equipped with an infrared camera that connects to a compact computer. It translates the patients' blinks and eye movements into commands, which are then converted into speech through earphones and a speaker. By leveraging advanced technology, EyeControl addresses significant communication barriers, enabling patients to express their needs and preferences more effectively.

Wooptix

Series B in 2023
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.

EBAMed

Series A in 2023
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

Abbelight

Venture Round in 2023
Abbelight specializes in super-resolution microscopy and membrane imaging, focusing on single molecule localization microscopy to enhance biological research. The company integrates consumables, hardware, and software to deliver advanced scientific solutions, allowing researchers in biology, pharmacology, and environmental studies to utilize super-resolved fluorescence microscopy for improved observation of biological samples. Abbelight aims to democratize access to these sophisticated techniques by simplifying their application while maintaining high performance standards. To support scientists throughout the research process, Abbelight offers expertise in sample preparation and result analysis, providing a comprehensive approach that combines chemistry, computer science, and optical instruments.

Quantrol Ox

Seed Round in 2023
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.

Enote

Venture Round in 2023
Enote is a digital sheet music application that revolutionizes how musicians access and interact with musical scores. The company employs advanced AI technology, specifically optical music recognition, to convert traditional paper sheet music into a fully digital format. This innovation provides musicians with instant access to a comprehensive library of scores, making sheet music more affordable, convenient, and interactive. Enote aims to serve over 200 million musicians worldwide, enabling them to easily find, prepare, and explore centuries of written music in a flexible digital format.

PASQAL

Series B in 2023
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

Kvantify

Grant in 2023
Kvantify, founded in 2022 and headquartered in Copenhagen, Denmark, specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. The company's platform focuses on enhancing drug discovery processes by employing proprietary physics-based methods to improve the quality of compounds tested in laboratories. By providing advanced computational drug technology, Kvantify enables life sciences companies to accelerate small molecule research and obtain actionable results that significantly impact their operations.

Infinite Orbits

Pre Seed Round in 2022
Infinite Orbits is a satellite servicing company that specializes in extending the operational lifespan of geostationary (GEO) telecommunication satellites. The company offers a comprehensive platform that addresses various challenges associated with satellite maintenance, including orbit correction and de-orbiting services. Utilizing advanced software and computer technologies, Infinite Orbits provides sensors that enhance situational awareness, allowing for autonomous navigation in orbit. This capability enables the company to deliver reliable in-orbit services to satellite operators globally, thereby facilitating more efficient management of satellite operations.

ELEM Biotech

Pre Seed Round in 2022
ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human beings using advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed Alya Red, a suite of simulation tools designed for the medical device and pharmaceutical industries. Utilizing a Software-as-a-Service model, Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients. By integrating high-performance computing, computational biomechanics, and data analysis, ELEM's technology enables biomedical companies and clinicians to improve diagnoses, plan treatments, and optimize drug delivery and medical devices.

Treble

Grant in 2022
Treble Technologies develops advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. The company specializes in acoustics design software that enables the creation of visually accurate and realistic virtual acoustics. By streamlining the processes of importing, exporting, and reconfiguring models, Treble's solutions help reduce risk and ensure that designs meet regulatory and certification requirements. Their technology is applied across various sectors, including automotive, building design, immersive reality, and artificial intelligence. Through its innovative platform, Treble empowers studios and artists to lower costs, mitigate risks, and enhance client engagement while delivering high-quality designs.

Treble

Seed Round in 2022
Treble Technologies develops advanced wave-based sound simulation products tailored for the architecture, engineering, and construction (AEC) industry. The company specializes in acoustics design software that enables the creation of visually accurate and realistic virtual acoustics. By streamlining the processes of importing, exporting, and reconfiguring models, Treble's solutions help reduce risk and ensure that designs meet regulatory and certification requirements. Their technology is applied across various sectors, including automotive, building design, immersive reality, and artificial intelligence. Through its innovative platform, Treble empowers studios and artists to lower costs, mitigate risks, and enhance client engagement while delivering high-quality designs.

Alpine Quantum Technologies GmbH

Grant in 2022
AQT is a quantum computing business creating the first general-purpose quantum computer. They are developing general-purpose quantum information processors that will support a variety of industrial applications. They employ a method based on scalable trapped ions that combines unrivaled physical performance, phenomenal qubit control, and proven optical networkability.

Alpine Quantum Technologies GmbH

Venture Round in 2022
AQT is a quantum computing business creating the first general-purpose quantum computer. They are developing general-purpose quantum information processors that will support a variety of industrial applications. They employ a method based on scalable trapped ions that combines unrivaled physical performance, phenomenal qubit control, and proven optical networkability.

BeeOdiversity

Venture Round in 2022
BeeOdiversity is a company focused on promoting environmental preservation and sustainability through innovative strategies and tools. It assists corporations and local authorities in developing environmental projects that create value for both the environment and stakeholders. The company specializes in the regeneration and preservation of bee populations, leveraging their ecological significance to enhance biodiversity. BeeOdiversity also offers an environmental monitoring tool that assesses pollutants and the overall state of biodiversity, utilizing data interpretation software to help industries minimize pollution and maintain ecosystem balance. Through its scientific expertise and environmental coaching, the company aims to foster sustainable agricultural practices and contribute positively to society and the environment.

BeeOdiversity

Grant in 2022
BeeOdiversity is a company focused on promoting environmental preservation and sustainability through innovative strategies and tools. It assists corporations and local authorities in developing environmental projects that create value for both the environment and stakeholders. The company specializes in the regeneration and preservation of bee populations, leveraging their ecological significance to enhance biodiversity. BeeOdiversity also offers an environmental monitoring tool that assesses pollutants and the overall state of biodiversity, utilizing data interpretation software to help industries minimize pollution and maintain ecosystem balance. Through its scientific expertise and environmental coaching, the company aims to foster sustainable agricultural practices and contribute positively to society and the environment.

Quantrol Ox

Grant in 2022
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.

AugmedIT B.V.

Grant in 2022
AugmedIT B.V. is a medical software company based in Amsterdam, the Netherlands, founded in 2018. The company focuses on developing augmented and mixed reality tools that enhance surgical procedures by enabling surgeons to create holograms of patients. AugmedIT specializes in applications related to neurosurgery, medical education, and holographic visualization, as well as neuronavigation. Through its innovative technology, the company aims to improve surgical precision and training in the medical field.

Infinite Orbits

Grant in 2022
Infinite Orbits is a satellite servicing company that specializes in extending the operational lifespan of geostationary (GEO) telecommunication satellites. The company offers a comprehensive platform that addresses various challenges associated with satellite maintenance, including orbit correction and de-orbiting services. Utilizing advanced software and computer technologies, Infinite Orbits provides sensors that enhance situational awareness, allowing for autonomous navigation in orbit. This capability enables the company to deliver reliable in-orbit services to satellite operators globally, thereby facilitating more efficient management of satellite operations.

ELEM Biotech

Grant in 2022
ELEM Biotech SL is a biomedical software company based in Barcelona, Spain, that specializes in creating virtual human beings using advanced mathematical modeling and cloud computing. Founded in 2018 by researchers from the Barcelona Supercomputing Center, ELEM has developed Alya Red, a suite of simulation tools designed for the medical device and pharmaceutical industries. Utilizing a Software-as-a-Service model, Alya Red allows for the simulation of cardiovascular and respiratory systems on virtual patients. By integrating high-performance computing, computational biomechanics, and data analysis, ELEM's technology enables biomedical companies and clinicians to improve diagnoses, plan treatments, and optimize drug delivery and medical devices.

CorTec

Grant in 2022
CorTec is a developer and manufacturer focused on creating advanced medical devices for neuromodulation and brain-computer interfaces. The company has spent a decade on research and development, culminating in the innovative CorTec Brain Interchange™ System. This unique platform allows researchers and clinicians to devise novel therapies for neurological disorders. Central to this system are the °AirRay™ electrode arrays, which are laser-structured, soft, and flexible, ensuring a gentle fit to the brain's contours for reliable, permanent recordings. The implanted electronics, protected by biocompatible ceramic encapsulation, preprocess data and include a custom microchip developed with the University of Ulm. This microchip amplifies and digitizes neuronal signals across multiple channels, while eliminating the need for battery replacements through an external inductive power supply. Furthermore, CorTec provides additional support, services, and components related to the Brain Interchange System to Medtech companies and startups in the neurotechnology sector.

Qu & Co

Grant in 2022
Qu & Co is a prominent developer of quantum-computational algorithms and software, focusing on the optimization of specialty chemicals, pharmaceuticals, and functional materials. The company’s software enhances in-house discovery and optimization processes by advancing novel quantum-computational chemistry methods and seamlessly integrating with existing chemistry and material-science workflows. This enables industries such as pharmaceuticals to conduct complex chemistry and multiphysics simulations on future quantum processors. In January 2022, Qu & Co merged with PASQAL, a leader in neutral atom-based quantum hardware, solidifying its position as a key player in the European quantum computing sector.

Idoven

Grant in 2022
Idoven is a pioneering company that has created an innovative cardiology-as-a-service platform utilizing artificial intelligence to enhance the ability of both cardiologists and non-specialist clinicians to identify, triage, and diagnose heart conditions on a large scale. The platform analyzes long-duration electrocardiograms to detect alterations in cardiac electrical activity and arrhythmias, allowing for early diagnosis and prevention of serious cardiac diseases, including myocardial infarction and sudden death. Idoven collaborates with notable partners such as AstraZeneca, Abbott, and Google, and has received investments from prominent firms like Insight Partners and Northzone. The company has been recognized with several prestigious awards for its technology, including accolades from the European Innovation Council and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. Additionally, Idoven has been named one of the top 50 companies in Digital Health by CB Insights for 2023.

Abzu

Grant in 2022
Abzu is a scientific artificial intelligence company founded in January 2018, with offices in Copenhagen, Denmark, and Barcelona, Spain. The company develops the QLattice, an innovative AI platform that aims to challenge conventional black box AI by providing transparent and explainable models. Abzu's technology is designed to assist pharmaceutical and biotech companies in accelerating drug development processes. By unlocking new disease mechanisms, discovering novel biomarkers, and validating multiple targets simultaneously, Abzu enables these companies to reduce research and development costs and enhance their discovery capabilities. Through its pioneering approach, Abzu inspires data scientists to adopt a more scientific methodology in their work.

Quanturi Oy

Grant in 2022
Quanturi Oy is a Finnish company founded in 2016 and headquartered in Espoo, specializing in continuous monitoring solutions for fermentable products. The company develops and markets connected objects and systems for data analysis, focusing on agricultural, forestry, and waste management sectors. Its product offerings include wireless monitoring systems for compost temperature, grain management, hay monitoring, and other industrial temperature applications. Quanturi Oy also sells its products online and has expanded its presence to several countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium.

Quanturi Oy

Venture Round in 2022
Quanturi Oy is a Finnish company founded in 2016 and headquartered in Espoo, specializing in continuous monitoring solutions for fermentable products. The company develops and markets connected objects and systems for data analysis, focusing on agricultural, forestry, and waste management sectors. Its product offerings include wireless monitoring systems for compost temperature, grain management, hay monitoring, and other industrial temperature applications. Quanturi Oy also sells its products online and has expanded its presence to several countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium.

PhoneOptika

Venture Round in 2022
PhoneOptika specializes in the development of advanced thin optical film technology aimed at enhancing user experience and safety while interacting with digital displays. The company focuses on creating innovative products that improve the quality of viewing on devices such as mobile phones, tablets, and control monitors. By prioritizing both user engagement and safety, PhoneOptika is committed to delivering solutions that significantly enhance the way individuals interact with digital technology.

Qubit Pharmaceuticals

Seed Round in 2022
Qubit Pharmaceuticals is a Paris-based company founded in 2020 that specializes in drug discovery technology. Established through collaboration among notable institutions such as CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, it draws on over 20 years of research and development recognized by prestigious awards. The company has developed a drug discovery simulation platform that aims to reduce both the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform conducts virtual screening and visualization to identify promising drug candidates. This innovative approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.

Enote

Grant in 2022
Enote is a digital sheet music application that revolutionizes how musicians access and interact with musical scores. The company employs advanced AI technology, specifically optical music recognition, to convert traditional paper sheet music into a fully digital format. This innovation provides musicians with instant access to a comprehensive library of scores, making sheet music more affordable, convenient, and interactive. Enote aims to serve over 200 million musicians worldwide, enabling them to easily find, prepare, and explore centuries of written music in a flexible digital format.

PASQAL

Grant in 2022
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

PeekMed

Grant in 2022
PeekMed is a company based in Braga, Portugal, that specializes in 3D pre-operative planning software for orthopedic surgery. Founded in 2015 by Jaime Campos, Sara Silva, and João Pedro Ribeiro, PeekMed's system is designed to enhance the precision of surgical procedures while simultaneously reducing costs. The software allows orthopedic surgeons to plan a variety of operations, including total joint replacements, osteotomies, and fracture reductions. It enables intuitive surgical sectioning of bones to correct deformities and facilitates the planning of trauma-related surgeries. Additionally, PeekMed's platform supports the storage and retrieval of patient studies, allowing surgeons to access medical images efficiently. The output from the system can be integrated with navigation systems, 3D printers, robotics, and mobile devices, further enhancing the surgical process and patient outcomes.

SAALG Geomechanics

Grant in 2022
SAALG Geomechanics SL, founded in 2016 and based in Barcelona, Spain, specializes in developing software for real-time analysis of ground conditions during civil engineering projects. The company provides advanced geological and numerical services, including numerical model calibrations and characterization of soil and rock parameters through back-analysis and inverse analysis. Its offerings include 2D and 3D geomechanical and geotechnical simulations, primarily focused on applications such as tunnel excavations, large and deep excavations, reinforced earth retaining walls, and wellbore stability analysis. By leveraging machine learning and real-time data analysis technology, SAALG Geomechanics enables construction companies to anticipate potential risks associated with ground movement, thereby optimizing project management, minimizing risks, and enhancing efficiency.

Multiverse Computing

Venture Round in 2021
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.

Multiverse Computing

Grant in 2021
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Founded in 2019, the company specializes in creating quantum computing software that addresses complex financial and macro-economic challenges. Its products are tailored for various applications, including portfolio optimization, risk analysis, and market simulation. By leveraging probabilistic and nondeterministic technologies, Multiverse Computing aims to help organizations across diverse sectors such as banking, energy, manufacturing, and logistics navigate the complexities of the second quantum revolution, ultimately providing them with a competitive advantage in their respective industries.

Enote

Seed Round in 2021
Enote is a digital sheet music application that revolutionizes how musicians access and interact with musical scores. The company employs advanced AI technology, specifically optical music recognition, to convert traditional paper sheet music into a fully digital format. This innovation provides musicians with instant access to a comprehensive library of scores, making sheet music more affordable, convenient, and interactive. Enote aims to serve over 200 million musicians worldwide, enabling them to easily find, prepare, and explore centuries of written music in a flexible digital format.

Sympower

Grant in 2021
Sympower is a developer of sustainable energy solutions aimed at addressing fluctuations in electricity supply and demand. The company partners with industry leaders to enhance grid stability and advance the transition to a net-zero future. By utilizing advanced and automated flexibility capabilities, Sympower's non-intrusive software allows customers to temporarily adjust the power of their systems, machines, and processes when the grid is out of balance. This technology aggregates electrical appliances and integrates with smart systems to optimize energy usage, enabling customers to shift consumption to more cost-effective times and provide real-time balancing of electricity. Through these innovations, Sympower enhances the value of energy assets while facilitating a fully renewable energy grid.

Wooptix

Venture Round in 2021
Wooptix S.L., founded in 2014 and headquartered in Madrid, Spain, specializes in advanced imaging technologies. The company develops light field and wavefront phase imaging software that captures comprehensive information about light, utilizing the full resolution of sensors. This innovative platform allows for three-dimensional modulation of images across various camera setups, producing volumetric images and videos with enhanced data points and high frame rates. By focusing on improving human interaction with the environment, Wooptix aims to redefine the way users perceive and engage with their surroundings, offering new possibilities for image quality and post-processing capabilities.

Spika Tech

Grant in 2021
Spika Tech is a Madrid-based company established in 2015, focused on research and development in the technological sector. The company provides a range of services aimed at assisting businesses with their projects, including virtual reality, augmented reality, complex software application development, and artificial intelligence. Additionally, Spika Tech specializes in creating logos, corporate identities, presentations, websites, applications, and online stores. By leveraging the latest techniques in design and programming, Spika Tech aims to enhance the quality of development processes for its clients.

Idoven

Grant in 2021
Idoven is a pioneering company that has created an innovative cardiology-as-a-service platform utilizing artificial intelligence to enhance the ability of both cardiologists and non-specialist clinicians to identify, triage, and diagnose heart conditions on a large scale. The platform analyzes long-duration electrocardiograms to detect alterations in cardiac electrical activity and arrhythmias, allowing for early diagnosis and prevention of serious cardiac diseases, including myocardial infarction and sudden death. Idoven collaborates with notable partners such as AstraZeneca, Abbott, and Google, and has received investments from prominent firms like Insight Partners and Northzone. The company has been recognized with several prestigious awards for its technology, including accolades from the European Innovation Council and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. Additionally, Idoven has been named one of the top 50 companies in Digital Health by CB Insights for 2023.

Qubit Pharmaceuticals

Grant in 2021
Qubit Pharmaceuticals is a Paris-based company founded in 2020 that specializes in drug discovery technology. Established through collaboration among notable institutions such as CNAM, CNRS, the University of Texas at Austin, Sorbonne University, and Washington University, it draws on over 20 years of research and development recognized by prestigious awards. The company has developed a drug discovery simulation platform that aims to reduce both the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, the platform conducts virtual screening and visualization to identify promising drug candidates. This innovative approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.

PASQAL

Series A in 2021
PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

Idoven

Seed Round in 2021
Idoven is a pioneering company that has created an innovative cardiology-as-a-service platform utilizing artificial intelligence to enhance the ability of both cardiologists and non-specialist clinicians to identify, triage, and diagnose heart conditions on a large scale. The platform analyzes long-duration electrocardiograms to detect alterations in cardiac electrical activity and arrhythmias, allowing for early diagnosis and prevention of serious cardiac diseases, including myocardial infarction and sudden death. Idoven collaborates with notable partners such as AstraZeneca, Abbott, and Google, and has received investments from prominent firms like Insight Partners and Northzone. The company has been recognized with several prestigious awards for its technology, including accolades from the European Innovation Council and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. Additionally, Idoven has been named one of the top 50 companies in Digital Health by CB Insights for 2023.

EyeControl

Grant in 2020
EyeControl is a pioneer in medical technology focused on innovative communication solutions for healthcare. The company has developed a unique device aimed at improving the quality of life for patients with locked-in syndrome, particularly those suffering from ALS. This device consists of a simple glass frame equipped with an infrared camera that connects to a compact computer. It translates the patients' blinks and eye movements into commands, which are then converted into speech through earphones and a speaker. By leveraging advanced technology, EyeControl addresses significant communication barriers, enabling patients to express their needs and preferences more effectively.

EyeControl

Series A in 2020
EyeControl is a pioneer in medical technology focused on innovative communication solutions for healthcare. The company has developed a unique device aimed at improving the quality of life for patients with locked-in syndrome, particularly those suffering from ALS. This device consists of a simple glass frame equipped with an infrared camera that connects to a compact computer. It translates the patients' blinks and eye movements into commands, which are then converted into speech through earphones and a speaker. By leveraging advanced technology, EyeControl addresses significant communication barriers, enabling patients to express their needs and preferences more effectively.

SiriusXT

Grant in 2020
SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

Robo Wunderkind

Grant in 2020
Robo Wunderkind develops innovative robotics kits aimed at teaching children coding and robotics through interactive play. The company manufactures smartphone-controlled robotic devices that include various hands-on kits equipped with sensors and motors, allowing them to react to noise, light, and gestures. These kits come with comprehensive educational materials and online tutorials, enabling children to build, program, and experiment with robots. By engaging with these products, children enhance their curiosity, nurture their creativity, and develop essential problem-solving skills.

SiriusXT

Venture Round in 2020
SiriusXT Limited, based in Dublin, Ireland, specializes in the development and manufacturing of a soft x-ray microscope known as the SXT system. Founded in 2015, the company primarily serves researchers in disease research and drug discovery. The microscope employs a vacuum-based laser-produced plasma light source, enabling high-resolution imaging of the 3D internal structure of cells in their native, fully hydrated state. This technology is akin to a CT scan for cells, allowing for detailed visualization without the need for stains or contrast agents. The SXT system is particularly beneficial for disease researchers, pharmaceutical companies, and biotechnologists, as it facilitates the understanding of disease pathways, protein-drug interactions, and bio-engineering processes. As the first high-throughput, bench-top soft x-ray microscope, SiriusXT's system can produce full cell 3D tomographs in a matter of minutes, significantly advancing imaging capabilities in scientific research.

Weber Hospital Systems

Grant in 2020
Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Seervision

Grant in 2020
Seervision AG, a Swiss startup founded in 2016 and based in Zurich, specializes in developing innovative software for camera automation aimed at enhancing video production efficiency. Originally conceived at ETH Zurich to improve live lecture recordings, the company has evolved into a dynamic enterprise with over 30 employees. The Seervision Suite now automates workflows primarily for corporate studios, stage events, and educational spaces. By leveraging advanced video analysis algorithms and technologies such as motion control, computer vision, and machine learning, Seervision enables fully automated productions, including autonomous camera tracking and facial recognition. This integration simplifies live production workflows, making it easier for users to manage hybrid meeting experiences and other video production needs.

Weber Hospital Systems

Venture Round in 2020
Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Robo Wunderkind

Venture Round in 2020
Robo Wunderkind develops innovative robotics kits aimed at teaching children coding and robotics through interactive play. The company manufactures smartphone-controlled robotic devices that include various hands-on kits equipped with sensors and motors, allowing them to react to noise, light, and gestures. These kits come with comprehensive educational materials and online tutorials, enabling children to build, program, and experiment with robots. By engaging with these products, children enhance their curiosity, nurture their creativity, and develop essential problem-solving skills.

EBAMed

Grant in 2020
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

Nimesis

Grant in 2020
Nimesis Technology specializes in the design, manufacture, and sale of shape memory alloys and related products and services. The company focuses on advancing mechanical and industrial engineering technologies to enhance the production of high-temperature shape memory alloys. Nimesis employs innovative alloy inspection software that evaluates the thermo-mechanical behavior of complex alloys, facilitating a comprehensive approach that spans design, development, prototyping, control, and component qualification. This technology allows businesses to benefit from mechanical simulations and the precise tuning of shape memory components, promoting efficiency and effectiveness in industrial applications.

Hafnium Labs

Grant in 2019
Hafnium Labs develops software aimed at providing reliable physical property data for molecules and mixtures, primarily serving the chemicals, energy, and pharmaceutical sectors. The company has created an innovative system that merges advanced predictive methods, including quantum chemistry and artificial intelligence, with experimental data. This approach enables Hafnium Labs to deliver accurate predictions of physical properties while also quantifying the uncertainty associated with each prediction. By offering tools that support decision-making throughout the stages of molecular discovery and process optimization, Hafnium Labs empowers researchers and engineers to tackle significant challenges in chemistry, ultimately contributing to advancements that benefit healthcare, agriculture, and energy technologies.

Picterus

Venture Round in 2019
Picterus is developing a smartphone application aimed at diagnosing jaundice in newborns, a condition that contributes to over 100,000 deaths annually, particularly in impoverished areas of Sub-Saharan Africa and South Asia. Existing screening devices are prohibitively expensive, often costing around $7,000, which limits access in low-resource settings. The app utilizes patented biomedical optics technology to provide accurate estimates of jaundice levels while accounting for variations in skin pigmentation. This innovation addresses the growing need for affordable and effective diagnostic tools, especially given the trend of shorter hospital stays post-birth and the rising rates of jaundice-related hospital readmissions. By enabling parents to monitor their child's jaundice levels at home, Picterus aims to improve health outcomes for vulnerable populations.

Abbelight

Venture Round in 2019
Abbelight specializes in super-resolution microscopy and membrane imaging, focusing on single molecule localization microscopy to enhance biological research. The company integrates consumables, hardware, and software to deliver advanced scientific solutions, allowing researchers in biology, pharmacology, and environmental studies to utilize super-resolved fluorescence microscopy for improved observation of biological samples. Abbelight aims to democratize access to these sophisticated techniques by simplifying their application while maintaining high performance standards. To support scientists throughout the research process, Abbelight offers expertise in sample preparation and result analysis, providing a comprehensive approach that combines chemistry, computer science, and optical instruments.

Tessares

Venture Round in 2019
Tessares is a Belgian startup founded in 2015, specializing in software that enhances Internet access performance and quality. The company focuses on developing solutions based on Multipath TCP (MPTCP) technology, which allows network operators to combine multiple access technologies, effectively increasing available bandwidth and improving user experience. Tessares’ flagship offering is the Hybrid Access Solution, which creates a more efficient and faster Internet connection without the need for extensive infrastructure investments. The company was established by key developers of the MPTCP protocol and has garnered significant initial funding from Proximus and VIVES. By leveraging its technical expertise, Tessares aims to optimize the Internet experience for clients across various geographic areas.

SynHet

Grant in 2019
SynHet specializes in the research and development of a diverse array of heterocycles for applications in agrochemicals, pharmaceuticals, and life sciences. The company manufactures organic and fine chemical products, leveraging an extensive global network of chemists to design and execute synthesis efficiently. By utilizing advanced technologies, including fully automated purification processes, SynHet is able to deliver compounds more rapidly and cost-effectively than traditional methods. This innovative approach enables the company to serve a wide range of global customers while enhancing its capabilities in scalable robotic synthesis.

BrachyDOSE

Grant in 2019
BrachyDOSE is the game changing cancer treatment quality control tool to empower oncology doctors to provide 100% accurate and error free radiotherapy treatment. Solution solves a problem touching 200 mln patients World Wide and +2000 hospitals in both Europe and the USA. This is a new approach of combining hardware dose measurement tool with deep learning algorithms to provide high accuracy data. It will help to reduce overall treatment costs per patient by 3-5 times, to saves up to 50% of doctors' and medical specialists' time for procedure preparation and will help cancer patient to came back to normal life sooner. BrachyDOSE solution consists of two parts: hardware and software. The radiation dose measurement tool – called sensor (hardware), a scanner to retrieve the data (hardware) and the injury prediction algorithm giving the decision support for a doctor (software). The sensor is in a shape of the flexible tube, it is disposable and at least one must be used during the procedure. One to five sensors could be used for a single procedure, according to the doctor’s prescription and the specific treatment plan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.